Sofinnova Venture Partners Vi L P - Net Worth and Insider Trading
Sofinnova Venture Partners Vi L P Net Worth
The estimated net worth of Sofinnova Venture Partners Vi L P is at least $2,085 dollars as of 2024-09-20. Sofinnova Venture Partners Vi L P is the 10% Owner of Ocera Therapeutics Inc and owns about 1,165 shares of Ocera Therapeutics Inc (OCRX) stock worth over $2,085. Details can be seen in Sofinnova Venture Partners Vi L P's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sofinnova Venture Partners Vi L P has not made any transactions after 2013-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sofinnova Venture Partners Vi L P
Sofinnova Venture Partners Vi L P Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sofinnova Venture Partners Vi L P owns 4 companies in total, including Marinus Pharmaceuticals Inc (MRNS) , Ocera Therapeutics Inc (OCRX) , and Anthera Pharmaceuticals Inc (ANTH) among others .
Insider Ownership Summary of Sofinnova Venture Partners Vi L P
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRNS | Marinus Pharmaceuticals Inc | 2016-10-20 | 10 percent owner |
| OCRX | Ocera Therapeutics Inc | 2014-03-18 | 10 percent owner |
| ANTH | Anthera Pharmaceuticals Inc | 2011-12-30 | 10 percent owner |
 | | 2007-05-01 | 10 percent owner |
Sofinnova Venture Partners Vi L P Latest Holdings Summary
Sofinnova Venture Partners Vi L P currently owns a total of 1 stock. Sofinnova Venture Partners Vi L P owns 1,165 shares of Ocera Therapeutics Inc (OCRX) as of July 15, 2013, with a value of $2,085.
Latest Holdings of Sofinnova Venture Partners Vi L P
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCRX | Ocera Therapeutics Inc | 2013-07-15 | 1,165 | 1.79 | 2,085 |
Holding Weightings of Sofinnova Venture Partners Vi L P
Sofinnova Venture Partners Vi L P Form 4 Trading Tracker
According to the SEC Form 4 filings, Sofinnova Venture Partners Vi L P has made a total of 0 transactions in Ocera Therapeutics Inc (OCRX) over the past 5 years. The most-recent trade in Ocera Therapeutics Inc is the acquisition of 32,597 shares on July 15, 2013, which cost Sofinnova Venture Partners Vi L P around $2 Million.
Insider Trading History of Sofinnova Venture Partners Vi L P
- 1
Sofinnova Venture Partners Vi L P Trading Performance
GuruFocus tracks the stock performance after each of Sofinnova Venture Partners Vi L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sofinnova Venture Partners Vi L P is 45.26%. GuruFocus also compares Sofinnova Venture Partners Vi L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sofinnova Venture Partners Vi L P within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sofinnova Venture Partners Vi L P's insider trading performs compared to the benchmark.
Performance of Sofinnova Venture Partners Vi L P
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.18 | | | | | |
| Relative Return to S&P 500(%) | 21.44 | | | | | |
Sofinnova Venture Partners Vi L P Ownership Network
Sofinnova Venture Partners Vi L P Owned Company Details
What does Marinus Pharmaceuticals Inc do?
Who are the key executives at Marinus Pharmaceuticals Inc?
Sofinnova Venture Partners Vi L P is the 10 percent owner of Marinus Pharmaceuticals Inc. Other key executives at Marinus Pharmaceuticals Inc include Chief Commercial Officer Christina Shafer , CFO Steven Pfanstiel , and Chief Medical Officer Joseph Hulihan .
Marinus Pharmaceuticals Inc (MRNS) Insider Trades Summary
Over the past 18 months, Sofinnova Venture Partners Vi L P made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 18,588 shares made by Scott Braunstein , a net sale of 7,730 shares made by Joseph Hulihan , and a net sale of 7,461 shares made by Steven Pfanstiel .
In summary, during the past 3 months, insiders sold 29,071 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 29,071 shares. During the past 18 months, 45,796 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 45,796 shares.
Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Marinus Pharmaceuticals Inc Insider Transactions
Sofinnova Venture Partners Vi L P Mailing Address
Above is the net worth, insider trading, and ownership report for Sofinnova Venture Partners Vi L P. You might contact Sofinnova Venture Partners Vi L P via mailing address: 3000 Sand Hill Road, 4-250, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
